Structure

Physi-Chem Properties

Molecular Weight:  586.33
Volume:  632.102
LogP:  9.013
LogD:  5.372
LogS:  -4.84
# Rotatable Bonds:  9
TPSA:  82.06
# H-Bond Aceptor:  6
# H-Bond Donor:  1
# Rings:  6
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.232
Synthetic Accessibility Score:  6.468
Fsp3:  0.514
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.797
MDCK Permeability:  2.0470664821914397e-05
Pgp-inhibitor:  0.562
Pgp-substrate:  0.816
Human Intestinal Absorption (HIA):  0.055
20% Bioavailability (F20%):  0.979
30% Bioavailability (F30%):  0.674

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.066
Plasma Protein Binding (PPB):  88.53343963623047%
Volume Distribution (VD):  2.965
Pgp-substrate:  8.640301704406738%

ADMET: Metabolism

CYP1A2-inhibitor:  0.135
CYP1A2-substrate:  0.145
CYP2C19-inhibitor:  0.751
CYP2C19-substrate:  0.606
CYP2C9-inhibitor:  0.931
CYP2C9-substrate:  0.494
CYP2D6-inhibitor:  0.572
CYP2D6-substrate:  0.113
CYP3A4-inhibitor:  0.816
CYP3A4-substrate:  0.754

ADMET: Excretion

Clearance (CL):  14.707
Half-life (T1/2):  0.011

ADMET: Toxicity

hERG Blockers:  0.949
Human Hepatotoxicity (H-HT):  0.985
Drug-inuced Liver Injury (DILI):  0.583
AMES Toxicity:  0.012
Rat Oral Acute Toxicity:  0.987
Maximum Recommended Daily Dose:  0.965
Skin Sensitization:  0.275
Carcinogencity:  0.911
Eye Corrosion:  0.003
Eye Irritation:  0.007
Respiratory Toxicity:  0.97

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC476255

Natural Product ID:  NPC476255
Common Name*:   BIMUUWRNJBALEP-AWNOVZCOSA-N
IUPAC Name:   n.a.
Synonyms:   3-O-Geranylforbesione
Standard InCHIKey:  BIMUUWRNJBALEP-AWNOVZCOSA-N
Standard InCHI:  InChI=1S/C37H46O6/c1-21(2)11-10-12-24(7)20-41-29-19-28(38)31-32(39)27-17-25-18-30-35(8,9)43-36(34(25)40,16-15-23(5)6)37(27,30)42-33(31)26(29)14-13-22(3)4/h11,13,15,17,19-20,25,30,38H,10,12,14,16,18H2,1-9H3/b24-20+/t25-,30+,36+,37-/m1/s1
SMILES:  CC(=CCCC(=COC1=C(C2=C(C(=C1)O)C(=O)C3=CC4CC5C3(O2)C(C4=O)(OC5(C)C)CC=C(C)C)CC=C(C)C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL558747
PubChem CID:   45268895
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO13310 Garcinia hanburyi Species Clusiaceae Eukaryota n.a. latex n.a. PMID[17117343]
NPO13310 Garcinia hanburyi Species Clusiaceae Eukaryota n.a. fruit n.a. PMID[17117343]
NPO13310 Garcinia hanburyi Species Clusiaceae Eukaryota resin n.a. n.a. PMID[19072548]
NPO13310 Garcinia hanburyi Species Clusiaceae Eukaryota n.a. n.a. n.a. PMID[21486005]
NPO13310 Garcinia hanburyi Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO13310 Garcinia hanburyi Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO13310 Garcinia hanburyi Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT165 Cell Line HeLa Homo sapiens IC50 = 4090.0 nM PMID[448256]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC476255 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9808 High Similarity NPC94796
0.9747 High Similarity NPC62444
0.9686 High Similarity NPC193222
0.9679 High Similarity NPC475107
0.9679 High Similarity NPC286422
0.9679 High Similarity NPC43490
0.9623 High Similarity NPC476056
0.9568 High Similarity NPC475080
0.9563 High Similarity NPC223413
0.9497 High Similarity NPC476931
0.9497 High Similarity NPC131578
0.9437 High Similarity NPC189689
0.9387 High Similarity NPC169018
0.9387 High Similarity NPC476159
0.9268 High Similarity NPC118128
0.9264 High Similarity NPC476216
0.9264 High Similarity NPC55422
0.9264 High Similarity NPC47634
0.9264 High Similarity NPC63514
0.9264 High Similarity NPC75141
0.9259 High Similarity NPC475109
0.9217 High Similarity NPC98943
0.9212 High Similarity NPC476229
0.9212 High Similarity NPC476139
0.9162 High Similarity NPC233978
0.9157 High Similarity NPC162248
0.9146 High Similarity NPC41598
0.9146 High Similarity NPC40089
0.9146 High Similarity NPC476146
0.9146 High Similarity NPC158329
0.913 High Similarity NPC476929
0.9108 High Similarity NPC476162
0.9096 High Similarity NPC476152
0.9096 High Similarity NPC476311
0.9091 High Similarity NPC476196
0.9074 High Similarity NPC475106
0.9062 High Similarity NPC476930
0.9006 High Similarity NPC125969
0.8994 High Similarity NPC473607
0.8935 High Similarity NPC476199
0.8935 High Similarity NPC476210
0.8929 High Similarity NPC475398
0.8922 High Similarity NPC477529
0.8882 High Similarity NPC473729
0.8876 High Similarity NPC227275
0.8869 High Similarity NPC469393
0.8862 High Similarity NPC315306
0.8862 High Similarity NPC313717
0.8848 High Similarity NPC316262
0.8848 High Similarity NPC314653
0.8827 High Similarity NPC201127
0.8824 High Similarity NPC5671
0.8812 High Similarity NPC288534
0.8802 High Similarity NPC54903
0.8802 High Similarity NPC286074
0.8795 High Similarity NPC85047
0.8795 High Similarity NPC120857
0.8795 High Similarity NPC17274
0.878 High Similarity NPC103816
0.878 High Similarity NPC61382
0.8765 High Similarity NPC164427
0.8758 High Similarity NPC209760
0.8758 High Similarity NPC100134
0.872 High Similarity NPC313368
0.8712 High Similarity NPC474637
0.8704 High Similarity NPC476169
0.8696 High Similarity NPC477957
0.8696 High Similarity NPC470353
0.8696 High Similarity NPC210597
0.869 High Similarity NPC102810
0.869 High Similarity NPC20734
0.8683 High Similarity NPC469394
0.8675 High Similarity NPC472581
0.8675 High Similarity NPC469395
0.8671 High Similarity NPC470676
0.8671 High Similarity NPC473132
0.8671 High Similarity NPC473135
0.865 High Similarity NPC470352
0.8647 High Similarity NPC474276
0.8647 High Similarity NPC73899
0.8647 High Similarity NPC147363
0.8647 High Similarity NPC17105
0.8642 High Similarity NPC472799
0.8642 High Similarity NPC236756
0.8642 High Similarity NPC311579
0.8639 High Similarity NPC193698
0.8634 High Similarity NPC471229
0.8634 High Similarity NPC472580
0.8631 High Similarity NPC150131
0.8614 High Similarity NPC219861
0.8606 High Similarity NPC470810
0.8606 High Similarity NPC172687
0.8599 High Similarity NPC204469
0.8598 High Similarity NPC161650
0.8596 High Similarity NPC289244
0.8596 High Similarity NPC245975
0.859 High Similarity NPC477272
0.8589 High Similarity NPC471116
0.8588 High Similarity NPC91650
0.858 High Similarity NPC275878
0.858 High Similarity NPC152477
0.858 High Similarity NPC473996
0.8571 High Similarity NPC267117
0.8571 High Similarity NPC235610
0.8571 High Similarity NPC471115
0.8571 High Similarity NPC29777
0.8563 High Similarity NPC109180
0.8563 High Similarity NPC8927
0.8563 High Similarity NPC273959
0.8563 High Similarity NPC474240
0.8563 High Similarity NPC475656
0.8563 High Similarity NPC475148
0.8562 High Similarity NPC39195
0.8562 High Similarity NPC145467
0.8554 High Similarity NPC474351
0.8554 High Similarity NPC117985
0.8554 High Similarity NPC478134
0.8554 High Similarity NPC475883
0.8553 High Similarity NPC82534
0.8553 High Similarity NPC329678
0.8553 High Similarity NPC477955
0.8547 High Similarity NPC469345
0.8545 High Similarity NPC264932
0.8545 High Similarity NPC311574
0.8538 High Similarity NPC154986
0.8538 High Similarity NPC471969
0.8537 High Similarity NPC146636
0.8537 High Similarity NPC470354
0.8537 High Similarity NPC20530
0.8537 High Similarity NPC215917
0.8537 High Similarity NPC472050
0.8537 High Similarity NPC10754
0.8535 High Similarity NPC171870
0.8528 High Similarity NPC469405
0.8528 High Similarity NPC293286
0.8528 High Similarity NPC192189
0.8528 High Similarity NPC203080
0.8521 High Similarity NPC470377
0.8521 High Similarity NPC292233
0.8521 High Similarity NPC471975
0.8521 High Similarity NPC470374
0.8521 High Similarity NPC126204
0.8521 High Similarity NPC478059
0.8521 High Similarity NPC478060
0.8521 High Similarity NPC476459
0.8519 High Similarity NPC305965
0.8519 High Similarity NPC46882
0.8519 High Similarity NPC178484
0.8519 High Similarity NPC132990
0.8519 High Similarity NPC472636
0.8519 High Similarity NPC478148
0.8512 High Similarity NPC475888
0.8512 High Similarity NPC62261
0.8512 High Similarity NPC473908
0.8509 High Similarity NPC473016
0.8509 High Similarity NPC277032
0.8506 High Similarity NPC208069
0.8503 High Similarity NPC211107
0.8503 High Similarity NPC474150
0.8503 High Similarity NPC474162
0.8503 High Similarity NPC472402
0.85 High Similarity NPC308200
0.85 High Similarity NPC47388
0.85 High Similarity NPC470670
0.85 High Similarity NPC91902
0.85 High Similarity NPC473133
0.8497 Intermediate Similarity NPC246877
0.8497 Intermediate Similarity NPC221820
0.8494 Intermediate Similarity NPC299436
0.8494 Intermediate Similarity NPC474287
0.8494 Intermediate Similarity NPC195136
0.8494 Intermediate Similarity NPC472618
0.8494 Intermediate Similarity NPC243701
0.8494 Intermediate Similarity NPC475886
0.8491 Intermediate Similarity NPC470673
0.8491 Intermediate Similarity NPC271288
0.8491 Intermediate Similarity NPC117716
0.8491 Intermediate Similarity NPC470674
0.8488 Intermediate Similarity NPC86809
0.8488 Intermediate Similarity NPC98667
0.8488 Intermediate Similarity NPC294149
0.8488 Intermediate Similarity NPC232412
0.8485 Intermediate Similarity NPC272196
0.8485 Intermediate Similarity NPC196448
0.8485 Intermediate Similarity NPC281137
0.8485 Intermediate Similarity NPC52889
0.8485 Intermediate Similarity NPC65504
0.8485 Intermediate Similarity NPC282390
0.8485 Intermediate Similarity NPC210048
0.848 Intermediate Similarity NPC121333
0.848 Intermediate Similarity NPC472620
0.8476 Intermediate Similarity NPC31018
0.8476 Intermediate Similarity NPC207809
0.8476 Intermediate Similarity NPC234485
0.8476 Intermediate Similarity NPC477958
0.8476 Intermediate Similarity NPC471456
0.8476 Intermediate Similarity NPC217706
0.8476 Intermediate Similarity NPC175192
0.8476 Intermediate Similarity NPC255807
0.8476 Intermediate Similarity NPC48579

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476255 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8589 High Similarity NPD8443 Clinical (unspecified phase)
0.8485 Intermediate Similarity NPD7075 Discontinued
0.8424 Intermediate Similarity NPD3882 Suspended
0.8415 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8303 Intermediate Similarity NPD7819 Suspended
0.8274 Intermediate Similarity NPD5494 Approved
0.8261 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8193 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD7411 Suspended
0.815 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8121 Intermediate Similarity NPD4380 Phase 2
0.8081 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8063 Intermediate Similarity NPD2800 Approved
0.8037 Intermediate Similarity NPD2533 Approved
0.8037 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8037 Intermediate Similarity NPD2534 Approved
0.8037 Intermediate Similarity NPD2532 Approved
0.8024 Intermediate Similarity NPD6801 Discontinued
0.8024 Intermediate Similarity NPD1934 Approved
0.8012 Intermediate Similarity NPD1247 Approved
0.8012 Intermediate Similarity NPD6599 Discontinued
0.8012 Intermediate Similarity NPD6959 Discontinued
0.8 Intermediate Similarity NPD1549 Phase 2
0.7977 Intermediate Similarity NPD6166 Phase 2
0.7977 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7977 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD6799 Approved
0.7941 Intermediate Similarity NPD3749 Approved
0.7937 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7937 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7931 Intermediate Similarity NPD7473 Discontinued
0.7889 Intermediate Similarity NPD8434 Phase 2
0.7882 Intermediate Similarity NPD7768 Phase 2
0.7874 Intermediate Similarity NPD2403 Approved
0.787 Intermediate Similarity NPD2801 Approved
0.7865 Intermediate Similarity NPD7808 Phase 3
0.7836 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7824 Intermediate Similarity NPD3817 Phase 2
0.7814 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD1510 Phase 2
0.7809 Intermediate Similarity NPD7251 Discontinued
0.7791 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD919 Approved
0.7784 Intermediate Similarity NPD3818 Discontinued
0.7778 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD1512 Approved
0.7764 Intermediate Similarity NPD6099 Approved
0.7764 Intermediate Similarity NPD2796 Approved
0.7764 Intermediate Similarity NPD6100 Approved
0.7759 Intermediate Similarity NPD6232 Discontinued
0.7753 Intermediate Similarity NPD6797 Phase 2
0.774 Intermediate Similarity NPD5844 Phase 1
0.7709 Intermediate Similarity NPD6559 Discontinued
0.7697 Intermediate Similarity NPD7074 Phase 3
0.7692 Intermediate Similarity NPD8150 Discontinued
0.7688 Intermediate Similarity NPD1607 Approved
0.7688 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD6651 Approved
0.7683 Intermediate Similarity NPD3750 Approved
0.7673 Intermediate Similarity NPD1240 Approved
0.7667 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD1511 Approved
0.764 Intermediate Similarity NPD7054 Approved
0.7637 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD5403 Approved
0.7616 Intermediate Similarity NPD5402 Approved
0.7614 Intermediate Similarity NPD3926 Phase 2
0.7598 Intermediate Similarity NPD7472 Approved
0.7584 Intermediate Similarity NPD3751 Discontinued
0.7557 Intermediate Similarity NPD5711 Approved
0.7557 Intermediate Similarity NPD5710 Approved
0.7529 Intermediate Similarity NPD3226 Approved
0.7526 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD1243 Approved
0.7515 Intermediate Similarity NPD920 Approved
0.75 Intermediate Similarity NPD1471 Phase 3
0.75 Intermediate Similarity NPD5401 Approved
0.7485 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7457 Intermediate Similarity NPD1465 Phase 2
0.7432 Intermediate Similarity NPD8313 Approved
0.7432 Intermediate Similarity NPD8312 Approved
0.7419 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD2344 Approved
0.7381 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD3748 Approved
0.7378 Intermediate Similarity NPD2799 Discontinued
0.7368 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD3787 Discontinued
0.7333 Intermediate Similarity NPD1551 Phase 2
0.7329 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD7435 Discontinued
0.732 Intermediate Similarity NPD7696 Phase 3
0.732 Intermediate Similarity NPD7697 Approved
0.732 Intermediate Similarity NPD7698 Approved
0.7318 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD2346 Discontinued
0.7282 Intermediate Similarity NPD7870 Phase 2
0.7282 Intermediate Similarity NPD7871 Phase 2
0.7268 Intermediate Similarity NPD5953 Discontinued
0.7262 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD4628 Phase 3
0.7257 Intermediate Similarity NPD5761 Phase 2
0.7257 Intermediate Similarity NPD5760 Phase 2
0.7255 Intermediate Similarity NPD7907 Approved
0.7254 Intermediate Similarity NPD6780 Approved
0.7254 Intermediate Similarity NPD6781 Approved
0.7254 Intermediate Similarity NPD6777 Approved
0.7254 Intermediate Similarity NPD6776 Approved
0.7254 Intermediate Similarity NPD6778 Approved
0.7254 Intermediate Similarity NPD6782 Approved
0.7254 Intermediate Similarity NPD6779 Approved
0.7253 Intermediate Similarity NPD7286 Phase 2
0.7235 Intermediate Similarity NPD7390 Discontinued
0.7229 Intermediate Similarity NPD2935 Discontinued
0.7225 Intermediate Similarity NPD7458 Discontinued
0.7222 Intermediate Similarity NPD8151 Discontinued
0.7222 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD2309 Approved
0.7215 Intermediate Similarity NPD4749 Approved
0.7205 Intermediate Similarity NPD4908 Phase 1
0.72 Intermediate Similarity NPD37 Approved
0.7198 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD7228 Approved
0.7191 Intermediate Similarity NPD6234 Discontinued
0.7186 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7874 Approved
0.7175 Intermediate Similarity NPD4967 Phase 2
0.7175 Intermediate Similarity NPD4966 Approved
0.7175 Intermediate Similarity NPD4965 Approved
0.7172 Intermediate Similarity NPD7701 Phase 2
0.7169 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD7229 Phase 3
0.715 Intermediate Similarity NPD7801 Approved
0.7134 Intermediate Similarity NPD943 Approved
0.7126 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD7199 Phase 2
0.711 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD8320 Phase 1
0.7107 Intermediate Similarity NPD8319 Approved
0.7093 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD5124 Phase 1
0.7091 Intermediate Similarity NPD6355 Discontinued
0.7091 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD230 Phase 1
0.7083 Intermediate Similarity NPD4363 Phase 3
0.7083 Intermediate Similarity NPD4360 Phase 2
0.7073 Intermediate Similarity NPD4111 Phase 1
0.7073 Intermediate Similarity NPD4665 Approved
0.7062 Intermediate Similarity NPD7699 Phase 2
0.7062 Intermediate Similarity NPD7700 Phase 2
0.7055 Intermediate Similarity NPD4625 Phase 3
0.7053 Intermediate Similarity NPD4287 Approved
0.7047 Intermediate Similarity NPD4361 Phase 2
0.7047 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7043 Intermediate Similarity NPD6764 Approved
0.7043 Intermediate Similarity NPD6765 Approved
0.703 Intermediate Similarity NPD4060 Phase 1
0.7012 Intermediate Similarity NPD2313 Discontinued
0.7012 Intermediate Similarity NPD3268 Approved
0.7005 Intermediate Similarity NPD3057 Approved
0.7005 Intermediate Similarity NPD8366 Approved
0.7 Intermediate Similarity NPD2654 Approved
0.6995 Remote Similarity NPD6535 Approved
0.6995 Remote Similarity NPD6534 Approved
0.6995 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6988 Remote Similarity NPD447 Suspended
0.6981 Remote Similarity NPD1610 Phase 2
0.698 Remote Similarity NPD7782 Clinical (unspecified phase)
0.698 Remote Similarity NPD7783 Phase 2
0.6977 Remote Similarity NPD3300 Phase 2
0.6952 Remote Similarity NPD7685 Pre-registration
0.695 Remote Similarity NPD7584 Approved
0.6949 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6941 Remote Similarity NPD2424 Discontinued
0.6939 Remote Similarity NPD8285 Discontinued
0.6935 Remote Similarity NPD1729 Discontinued
0.6923 Remote Similarity NPD8127 Discontinued
0.6919 Remote Similarity NPD3533 Approved
0.6919 Remote Similarity NPD2972 Approved
0.6919 Remote Similarity NPD6823 Phase 2
0.6909 Remote Similarity NPD3764 Approved
0.6897 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6895 Remote Similarity NPD6784 Approved
0.6895 Remote Similarity NPD6785 Approved
0.689 Remote Similarity NPD6832 Phase 2
0.6882 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6875 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6872 Remote Similarity NPD8491 Approved
0.6871 Remote Similarity NPD2798 Approved
0.6871 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6869 Remote Similarity NPD2493 Approved
0.6869 Remote Similarity NPD2494 Approved
0.6864 Remote Similarity NPD7033 Discontinued
0.6862 Remote Similarity NPD7240 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data